BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36052044)

  • 1. Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Lai X; Wang A
    Comput Intell Neurosci; 2022; 2022():6336107. PubMed ID: 36052044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
    Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma.
    Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH
    Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of sorafenib combined with transcatheter hepatic arterial chemoembolization in treating intermediate-advanced hepatocellular carcinoma.
    Kuang J; Wan D; Wan P; Wu D
    J BUON; 2021; 26(3):868-874. PubMed ID: 34268947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Dahuang Zhechong Pills combined with TACE on VEGF, MMP-2, TGF-β1 and immune function of patients with primary liver cancer (blood stasis and collaterals blocking type)].
    Dai CM; Jin S; Zhang JZ
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):722-729. PubMed ID: 33645040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma.
    Yang Q; Li G; Wu X; Lin H; Wu W; Xie X; Zhu Y; Cai W; Shi C; Zhuo S
    Front Oncol; 2023; 13():1136366. PubMed ID: 37064142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.
    Fan J; He S; Zheng Y
    J BUON; 2019; 24(6):2411-2417. PubMed ID: 31983113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation.
    Lin JJ; Jin CN; Zheng ML; Ouyang XN; Zeng JX; Dai XH
    Chin J Integr Med; 2005 Jun; 11(2):104-10. PubMed ID: 16150196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma.
    Liu Q; Dai Y
    J BUON; 2020; 25(2):945-951. PubMed ID: 32521890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer.
    Zhang Q; Bian SQ; Lv W; Kou D; Hu HL; Guo SS; Cao ZS
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):239-246. PubMed ID: 31389607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
    Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
    Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
    J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
    Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu Y; Li Y; Wang X; Huang Y; Zhang Q; Shi K; Ran C; Hou J; Wang X
    J Altern Complement Med; 2020 Oct; 26(10):956-965. PubMed ID: 32614605
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of efficacy and safety between transarterial chemoembolization (TACE) combined with lenvatinib versus TACE combined with sorafenib in the treatment of intermediate and advanced hepatocellular carcinoma.
    Xu R; Ji X; Pei X; Yu Y
    Am J Transl Res; 2023; 15(2):1117-1128. PubMed ID: 36915764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
    Zhang H; Yang A; Zhang J
    J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
    Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
    [No Abstract]   [Full Text] [Related]  

  • 20. Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma.
    Kim S; Kim KH; Kim BK; Park JY; Ahn SH; Kim DY; Kim SU
    J Gastroenterol Hepatol; 2021 May; 36(5):1317-1325. PubMed ID: 33217054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.